Good morning, Enrique!
Back on Ecotrader, I recommended buying Indra shares at levels slightly above where they are currently trading. I decided to add this value to the list of Ecotrader recommendations because of the sector it is in, because it is one of the possible blue sapphires (candidates for the next Tressis Portfolio ECO 30 fund review) and because it has reached an area of very important theoretical support in the medium term, such as the 38.20% correction level of all previous gains, which lifted the title from a 2022 low of 7.25 to this year’s high of 21.75 euros. I continue to view the €16.20 level as a clear buying opportunity and expect a resumption of the flawless uptrend to new all-time highs above €21.75. Stop at 15.70-16 euros. If you want a little more security, wait to buy until the price breaks the €17.50 resistance.
Regarding Pharmamar, I can tell you that it is more of a hold than a buy, with the expectation of a rise to 97-100 euros, reaching which would mean a retracement of the 61.80% Fibonacci level of the previous big decline that I show you on the chart. diagram. If you have it, don’t sell until you see a weekly close that loses the previous week’s low and look for that target.
Hugs from Ecotrader
If you are interested in this type of analysis and can ask me any questions you deem relevant, I invite you to inquire about current promotions for access to elEconomista premium content: ECOTRADER. Call us without any obligation at 911 383 387 or write to me at joan.cabrero@eleconomista.es.
New news from the kings of Holland. While the Norwegians are dealing with pre-trial detention…
New code of ethics for full inclusion in Spain Fully inclusive Spain creates new Code…
He Congress Yesterday, Thursday, he finally approved tax reform, which includes a new design for…
It's a new Friday, and that means a new Bargain Hunt. Except, This is a…
Mercedes started at Las Vegas Grand Prix as a team that will win by doing…
Sandra Bullock in Alfonso Cuaron's Gravity © WARNER Lira plus late Google News Partager Facebook…